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Abstract objectives Data on renal dysfunction in sub-Saharan Africa, comparing urban and rural areas,
have not yet been reported. Therefore, we aimed to determine the distribution of low estimated
glomerular filtration rates (eGFRs) in urban and rural Tanzania, to describe factors associated with
low eGFR and to quantify fractions attributable to common risk factors.
methods We conducted a community-based survey of 1095 randomly selected Tanzanian adults
(≥18 years). A structured questionnaire and examinations were used to document sociodemographic
characteristics, diet, physical activity, anthropomorphic measurements and blood pressure. Blood tests
were performed for HIV infection, diabetes mellitus and creatinine. eGFR was calculated using two
equations recommended for African adults.
results Serum creatinine was available for 1043 participants: 170 in Mwanza city, 326 in district
towns and 547 in rural areas. Mean age was 35.5 years and 54% were females. The prevalence of
eGFR < 60 ml/min/1.73 m2 in these 3 strata was 2.3% (95% CI = 0.8–6.6%), 7.5% (4.7–11.8%)
and 7.4% (5.1–10.6%), respectively. When age standardised to the WHO world population,
prevalences were 3.8%, 10.1% and 8.1%. Factors associated with low eGFR included district town
residence, older age, greater wealth, less physical activity and hypertension. Only 21% of cases with
eGFR < 60 ml/min/1.73 m2 were attributable to HIV, hypertension or diabetes.
conclusions Decreased renal function is common in Tanzania, particularly in district towns, and
unique risk factors for kidney disease may exist in this population. Population-specific strategies for
prevention, early diagnosis and treatment of kidney disease are needed for Africa.
keywords renal disease, Tanzania, epidemiology, prevalence, risk factors, adults
Introduction
Despite the rising tide of non-communicable disease
(NCD) in sub-Saharan Africa (SSA), few studies have
assessed the burden of kidney disease in this region [1].
Health facility data indicate that kidney disease is com-
mon, including our own study from western Tanzania,
which demonstrated that kidney disease was the 6th lead-
ing cause of hospital deaths [2]. Studies of the general
population, though, are lacking. According to a recent
meta-analysis, only three high-quality epidemiological
surveys had been conducted in SSA, and none had com-
pared the prevalence of kidney disease in urban and rural
settings [1].
Risk factors for kidney disease in SSA are also poorly
described and may differ from those in the United States
and Europe [3,4], and between urban and rural areas
[3,5]. Infectious risk factors for kidney disease remain
common in SSA, particularly in rural areas [5]. Non-
infectious risk factors such as diabetes, hypertension and
obesity are now becoming increasingly prevalent, particu-
larly in urban areas [6]. Better understanding of risk fac-
tors for kidney disease in sub-Saharan Africa is critical
for planning clinical trials and improving services [3–5].
We determined estimated glomerular filtration rates
(eGFRs) in a large community survey of randomly
selected, representative samples of adults in rural commu-
nities, district towns and urban areas in north-western
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Tanzania. The objectives of our study were as follows: (i)
to determine the distribution of decreased eGFR in the
three study locations, (ii) to systematically describe fac-
tors associated with low eGFR and (iii) to quantify the
proportion of low eGFRs that were attributable to HIV,
hypertension and diabetes.
Methods
Study design and sampling
This study was part of a larger population survey of
chronic diseases that we conducted between May 2012
and April 2013 among adults (≥18 years) in north-wes-
tern Tanzania (in the Lake Zone located just south of
Lake Victoria). We used stratified, multistage sampling,
with five strata: a municipal area (Mwanza city), two dis-
trict towns (Geita and Kahama) and the rural communi-
ties corresponding to each district town. The adults
population of these municipal areas, district towns and
rural communities are similar to other parts of East
Africa with adult median age of ~33 years, ~55%
females, a median income of ~40 USD, ~25% secondary
education or higher and ~6% prevalence of HIV [7]. The
major tribe in the study area is the Sukuma tribe, a Bantu
ethnic group. We took an independent two-stage self-
weighting sample from each stratum, firstly sampling
areas with probability proportional to the number of
households, and secondly randomly sampling households
within these areas. Households (the primary sampling
unit) were eligible if they were located within 5 km of a
health facility. Selected households were visited, verbal
consent from household heads was obtained, a list of
adult household members prepared, and all resident
adults were invited to participate. Consenting participants
were recruited. The sampling strategy is described in
greater detail elsewhere [7].
Data collection
Consenting participants were interviewed in their homes
or communal places using a structured questionnaire
adapted from the WHO STEPwise approach to chronic
disease risk factor surveillance (STEPS) instrument [8].
We collected information on sociodemographic character-
istics and risk factors for non-communicable diseases
(NCDs) including alcohol use, smoking, diet and physical
activity. Weight and height were measured according to
the STEPS protocol. Three blood pressure (BP) measure-
ments were taken in seated participants after resting for
at least 15 min, using Omron digital automatic BP mon-
itor model M6 (Omron Health Care Manufacturing
Vietnam Co., Ltd, Binh Duong Province, Vietnam). The
third reading was used for analysis.
Laboratory methods
At the time of enrolment, venous blood samples were
obtained. Serum aliquots were stored in a portable free-
zer (20 °C) and transported (within 5 days) to the
National Institute for Medical Research Laboratory in
Mwanza city, where they were stored at 80 °C. Serum
samples were later transported to the MRC/UVRI
Uganda Research Unit on AIDS in Entebbe, where serum
creatinine was measured using Cobas Integra 400 Plus
Analyzer (Roche Diagnostic Limited, Switzerland), cali-
brated by the creatinine Jaffe 2 method. Capillary ran-
dom blood glucose (RBG) was measured using a
portable, battery-driven Accu-Check Aviva (Roche
Diagnostics GmbH, Mannheim, Germany), and rapid
HIV diagnostic tests were performed according to
national protocols. In study subjects with an elevated
RBG (≥7 mmol/l), a fasting blood sample was subse-
quently obtained for measurement of fasting blood glu-
cose (FBG). Other laboratory methods were previously
described in detail [7].
Definitions
The primary outcome of this study was decreased renal
function according to the estimated glomerular filtration
rate (eGFR). For this study, decreased renal function was
defined as eGFR<60 ml/min/1.73 m2 according to the
Kidney Disease Improving Global Outcomes (KDIGO)
guidelines [9]. The eGFR was calculated using the CKD-
EPI equation as this is recommended by KDIGO and is
the most accurate eGFR equation for African adults [9–
12]. The grade of renal function was also defined accord-
ing to KDIGO guidelines: normal (eGFR≥90); mildly
decreased (eGFR 60–89); mildly–moderately decreased
(eGFR 45–59); moderately–severely decreased (eGFR 30–
44); severely decreased (eGFR 15–29); and kidney failure
(eGFR < 15) [9]. For the sake of comparison, we also
calculated the eGFR using the Modified Diet Renal Dis-
ease (MDRD) equation. All eGFR calculations were per-
formed without the coefficient for ethnicity because this
coefficient has been shown to overestimate the actual
glomerular filtration rate among Africans [10–12].
Hypertension was defined as systolic blood pressure
≥140 mmHg and/or diastolic blood pressure ≥90 mmHg
or current antihypertensive therapy [13]. Diabetes melli-
tus was defined as FBG ≥7 mmol/L or RBG >11.1 mmol/
l or being on diabetes medication. Body mass index
(BMI, kg/m2) was classified as underweight (<18.5),
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normal (18.5 to <25), overweight (25 to <30) and obese
(≥30). Waist circumference >94 cm and >80 cm was clas-
sified as above normal (central obesity) for males and
females.
Statistical analysis
Data were double entered and verified in OpenClinica
version 3.0.1 (OpenClinica, Waltham, USA). We used the
survey commands of Stata version 13 (Stata Corporation,
College Station, USA) to account for the complex sam-
pling design, with standard errors adjusted for clustering
at the level of the primary sampling unit. We applied
strata sampling weights to account for differential proba-
bility of selection between strata, as has been described
in greater detail elsewhere [7].
We estimated the population prevalence of decreased
renal function based on the CKD-EPI and MDRD equa-
tions, stratified by location (Mwanza city, district towns
and rural), using weighted percentages and confidence
intervals (CI) but observed (i.e. unweighted) frequencies.
In addition, prevalences were age standardised using both
the United States 2000 population and the WHO world
population as references as we have previously reported
for hypertension and diabetes mellitus [7].
We assessed the agreement of the classification based
on the MDRD with that based on the CKD-EPI equa-
tion using a Kappa statistic, with the Landis and Koch
interpretation for the strength of agreement [14].
We used logistic and linear regression to investigate
factors associated with the prevalence of decreased renal
function (eGFR < 60 ml/min/1.73 m2, based on CKD-EPI
equation) and of mean eGFR, respectively, and estimated
regression coefficients (odds ratios (OR) and mean
change) and 95% CI using the Stata survey procedures to
adjust the standard errors for the survey design. Sampling
weights were not applied in the risk factor analyses. We
adjusted for age, sex and location a priori in all models,
so comparisons were essentially within location. We esti-
mated the population attributable fraction (PAF) of
decreased renal function for HIV, hypertension and dia-
betes using the adjusted ORs from the final model. The
joint PAF for HIV, hypertension and diabetes was calcu-
lated by generating a new variable to represent the eight
possible combinations of the 3 CDs: none of the 3, HIV
only, hypertension only, diabetes only, HIV and hyper-
tension, HIV and diabetes, hypertension and diabetes,
and all 3 CDs. This new variable was then included in a
logistic regression model adjusted for age, sex and loca-
tion. The adjusted (a)ORs from this model multiplied by
the proportion of cases of low eGFR in each of the cate-
gories by the attributable fraction in the exposed
(1-aOR)/aOR); these values were then summed to get the
overall PAF.
Potential determinants of mean eGFRs were examined
using a conceptual framework with three levels. Age, sex
and location were included in all models. Sociodemo-
graphic factors (e.g. education, marital status, income
group) were added one by one to the age-, sex- and loca-
tion-adjusted analysis and retained if associated with
mean eGFR at P < 0.10. Behavioural factors (e.g. smok-
ing, diet, alcohol intake) were then added one by one and
retained if they remained associated at P < 0.10. Associa-
tions with clinical factors (e.g. body mass index, hyper-
tension, diabetes) were subsequently determined in a
similar way. This strategy allowed us to assess the effects
of variables at each level of the framework, adjusted for
more distal variables.
Ethical considerations
This study was approved by the ethics committees of the
Tanzania National Institute for Medical Research and the
London School of Hygiene and Tropical Medicine. We
obtained written informed consent from all participants (or
by literate witnesses for illiterate participants) before
administering study procedures. Participants were inter-
viewed in private to ensure confidentiality. Participants
with any untreated or newly diagnosed conditions referred
to a local health facility for further assessment, counselling,
and long-term care and treatment. All procedures were con-
sistent with ethical standards of the Helsinki Declaration.
Results
Enrolment
Between August 2012 and April 2013, we sampled 625
households of which 563 (90%) agreed to participate.
There were 1374 eligible adults in the participating
households, and 1095 (80% of those eligible) consented
to the survey, resulting in an estimated 72% response
rate. Among adults surveyed, creatinine measurements
were available for 1043: 170 of 175 (97%) adults in
Mwanza city, 326 of 344 (95%) in district towns and
547 of 576 (95%) in rural areas.
Characteristics of the study population
Among 1043 study participants with data on eGFR, the
mean age was 35.5 years (SD = 15.3 years) and 566
(54.3%) were female; 852 (81.7%) had only a primary
education or less and 731 (74.4%) earned <64 USD per
month (Table 1). Regarding clinical characteristics, 197
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Table 1 Population characteristics and factors associated with decreased renal function (eGFR <60 ml/min/1.73 m2) among adults in a
population survey in north-western Tanzania, 2012–2013
Total N
(column %)*
Prevalence
of eGFR < 60
(row %)*
Unadjusted OR
(95% CI)†
Age-, sex-, and
residence-adjusted
OR (95% CI)†
Sociodemographic
Residence P = 0.11 P = 0.12
Mwanza city 170 (16.3%) 4 (2.4%) 1 1
District towns 326 (31.3%) 23 (7.1%) 3.15 (0.97–10.27) 3.37 (1.07–10.64)
Rural 547 (52.4%) 42 (7.7%) 3.45 (1.09–10.89) 2.96 (0.94–9.33)
Age group P < 0.001 P < 0.001
<25 years 293 (28.1%) 10 (3.4%) 1 1
25–34 years 326 (31.3%) 16 (4.9%) 1.46 (0.68–3.15) 1.45 (0.68–3.08)
35–44 years 167 (16.0%) 12 (7.2%) 2.19 (1.27–3.77) 2.16 (1.27–3.66)
≥45 years 257 (24.6%) 31 (12.1%) 3.88 (2.18–6.90) 3.82 (2.16–6.74)
Sex P = 0.34 P = 0.52
Male 477 (45.7%) 35 (7.3%) 1 1
Female 566 (54.3%) 34 (6.0%) 0.81 (0.52–1.26) 0.87 (0.57–1.34)
Education P = 0.12 P = 0.76
Secondary or above 191 (18.3%) 9 (4.7%) 1 1
Completed primary 491 (47.1%) 29 (5.9%) 1.27 (0.55–2.94) 0.91 (0.38–2.20)
None/incomplete primary 361 (34.6%) 31 (8.6%) 1.90 (0.90–4.03) 1.12 (0.47–2.66)
Marital status P = 0.06 P = 0.49
Married/living as married 674 (64.6%) 45 (6.7%) 1 1
Divorced/sep/widowed 163 (15.6%) 17 (10.4%) 1.63 (0.90–2.94) 1.46 (0.78–2.71)
Single 206 (19.8%) 7 (3.4%) 0.49 (0.22–1.12) 0.85 (0.24–3.03)
Income per month‡ P = 0.30 P = 0.18
Upper tertile (64 + USD) 251 (25.6%) 13 (5.2%) 1 1
Middle tertile (26–63 USD) 262 (26.7%) 22 (8.4%) 1.68 (0.86–3.28) 1.87 (0.95–3.69)
Lower tertile (<26 USD) 469 (47.8%) 30 (6.4%) 1.25 (0.66–2.36) 1.29 (0.65–2.58)
Items owned P = 0.02 P = 0.02
5+ 262 (25.1%) 24 (9.2%) 1 1
2–4 668 (64.0%) 35 (5.2%) 0.55 (0.36–0.84) 0.54 (0.35–0.83)
0–1 113 (10.8%) 10 (8.8%) 0.96 (0.43–2.15) 0.80 (0.33–1.91)
Behavioural
Smoking P = 0.18 P = 0.89
Never smoked 856 (82.1%) 52 (6.1%) 1 1
Ex–smoker 79 (7.6%) 8 (10.1%) 1.74 (0.91–3.35) 1.17 (0.60–2.29)
Current smoker 108 (10.4%) 9 (8.3%) 1.41 (0.62–3.19) 0.94 (0.38–2.31)
Alcohol consumption P = 0.34 P = 0.57
Never drinks 669 (64.1%) 40 (6.0%) 1 1
None in past 12 months 237 (22.7%) 21 (8.9%) 1.53 (0.84–2.80) 1.15 (0.60–2.23)
Drinking in past 12 months 137 (13.1%) 8 (5.8%) 0.98 (0.38–2.52) 0.71 (0.28–1.80)
Eats fruit/veg less than 5 days/week P = 0.05 P = 0.11
No 771 (73.9%) 58 (7.5%) 1 1
Yes 272 (26.1%) 11 (4.0%) 0.52 (0.27–1.00) 0.58 (0.30–1.14)
Days of vigorous physical activity/week§ P = 0.26 P = 0.07
5+ 500 (48.0%) 28 (5.6%) 1 1
1–4 135 (13.0%) 8 (5.9%) 1.06 (0.50–2.27) 1.31 (0.60–2.85)
None 407 (39.1%) 33 (8.1%) 1.49 (0.88–2.52) 1.81 (1.09–3.00)
Clinical
Body Mass Index (BMI) category (kg/m2)¶ P = 0.61 P = 0.83
Underweight (<18.5) 109 (10.5%) 11 (10.1%) 1.73 (0.69–4.29) 1.52 (0.62–3.77)
Normal (18.5–<25) 737 (71.0%) 45 (6.1%) 1 1
Overweight (25–<30) 123 (11.8%) 8 (6.5%) 1.07 (0.57–2.02) 0.97 (0.49–1.91)
Obese (≥30) 69 (6.6%) 5 (7.2%) 1.20 (0.51–2.81) 0.92 (0.37–2.28)
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(18.5%) were overweight or obese, 180 (17.3%) had
hypertension, 9 (0.9%) had diabetes mellitus and 87
(8.4%) were HIV seropositive.
Renal function outcomes
According to the CKD-EPI equation, the mean (95% CI)
eGFRs (ml/min/1.73 m2) were 114.5 (109.9–119.0), 110.2
(106.9–113.5) and 107.7 (105.4–110.1) in Mwanza city,
district towns and rural areas, respectively (Table 2). Simi-
lar estimates were obtained with the MDRD equation. The
prevalence (95% CI) of decreased renal function (defined
by eGFR<60 ml/min/1.73 m2) was 2.3% (0.8–6.6%),
7.5% (4.7–11.8%) and 7.4% (5.1–10.6%) in Mwanza
city, district towns and rural areas, respectively. There
were no cases of moderately–severe or severely decreased
eGFR in Mwanza city, compared with 2.7% in district
towns and 2.2% in rural areas. When standardised to the
US 2000 population, the prevalence of decreased renal
function was 5.1%, 11.0% and 9.4% in Mwanza city, dis-
trict towns and rural areas, respectively (Figure 1).
The agreement between the CKD-EPI equation with
the MDRD equations in the classification of decreased
renal function (eGFR < 60 ml/min/1.73 m2) was excel-
lent (kappa = 0.83) (Table 3). Study subjects with
eGFR<60 ml/min/1.73 m2 by the CKD-EPI equation (69/
69 (100%)) also had eGFR<60 ml/min/1.73 m2 by the
MDRD equation.
Factors associated with decreased renal function
People living in district towns had a higher odds of
eGFR < 60 ml/min/1.73 m2 (adjusted (a)OR = 3.37,
95% CI = 1.07–10.64) (Table 1). Increasing age was
Table 1 (Continued)
Total N
(column %)*
Prevalence
of eGFR < 60
(row %)*
Unadjusted OR
(95% CI)†
Age-, sex-, and
residence-adjusted
OR (95% CI)†
Central Obesityk P = 0.97 P = 0.70
No 784 (75.2%) 52 (6.6%) 1 1
Yes 259 (24.8%) 17 (6.6%) 0.99 (0.52–1.90) 0.85 (0.38–1.94)
Hypertension P = 0.003 P = 0.11
No 863 (82.7%) 46 (5.3%) 1 1
Yes 180 (17.3%) 23 (12.8%) 2.60 (1.41–4.78) 1.84 (0.87–3.89)
Systolic blood pressure (mmHg)
<120 448 (43.0%) 23 (5.1%) P = 0.005
1.20 (1.06–1.36)‡‡
P = 0.14
1.12 (0.96–1.30)‡‡
120–140 445 (42.7%) 28 (6.3%)
>140 150 (14.4%) 18 (12.0%)
Diastolic blood pressure (mmHg)
<80 748 (71.7%) 40 (5.3%) P = 0.008
1.35 (1.09–1.68)††
P = 0.13
1.22 (0.94–1.57)††
80–90 210 (20.1%) 16 (7.6%)
>90 85 (8.1%) 13 (15.3%)
Diabetes** P = 0.54 P = 0.84
No 1031 (99.1%) 67 (6.5%) 1 1
Yes 9 (0.9%) 1 (11.1%) 1.80 (0.26–12.24) 1.21 (0.19–7.84)
HIV positive†† P = 0.06 P = 0.08
No 947 (91.6%) 59 (6.2%) 1 1
Yes 87 (8.4%) 9 (10.3%) 1.74 (0.99–3.06) 1.68 (0.93–3.04)
*Actual number of respondents and proportions, without sampling weights applied.
†Standard errors and 95% CI adjusted for clustering in survey design.
‡Missing for 61 participants.
§Missing for one participant. Vigorous physical activity was defined as ‘activity that causes large increases in breathing or heart rate
like carrying or lifting heavy loads, very brisk walking, digging or construction work for at least 10 min continuously’.
¶Missing for five participants.
kCentral obesity was defined as a waist circumference of >0.94 for women and waist circumference >0.80 for men.
**Missing for three participants.
††HIV diagnosis missing for nine participants.
‡‡OR for 10 unit mmHg increase in blood pressure, modelled as a linear association with continuous covariate.
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strongly associated with decreased renal function. Adults
aged 35–44 years and ≥45 years had 2.16 (95%
CI = 1.27–3.66) and 3.82 (95% CI = 2.16–6.74) greater
adjusted odds of decreased renal function compared with
adults <25 years old, after adjusting for sex and resi-
dence. Similarly, people who were not engaged in vigor-
ous physical activity had greater odds of decreased renal
function (aOR = 1.81, 95% CI = 1.09–3.00), when com-
pared with those engaged in vigorous activity ≥5 days a
week. Decreased renal function was also associated with
ownership of household items, with prevalence highest
among those owning more items (P = 0.02). However,
the prevalence of decreased renal function was also rela-
tively higher among those in the lower income group vs
the middle income group.
Hypertension was associated with decreased renal func-
tion in the unadjusted analysis (OR = 2.60, 95%
CI = 1.41–4.78; P = 0.008) but this association was
weakened in the adjusted analysis (aOR = 1.84, 95%
CI = 0.87–3.89; P = 0.14). Similar trends were observed
for both systolic and diastolic blood pressures. We also
observed some evidence of an increased odds of
decreased renal function among those who were HIV
positive (aOR = 1.68, 95% CI = 0.93–3.04; P = 0.08).
Factors associated with mean eGFR
After adjustment, people living in district towns had a
lower mean eGFR (5.89 ml/min/1.73 m2, 95%
CI = [10.94, 0.84]) (Table 4). Age was strongly
Table 2 Mean serum creatinine and eGFR, and prevalence of decreased renal function among adults in a population survey in north-
western Tanzania, 2012–2013.
Mwanza city (n = 170) District towns (n = 326) Rural (n = 547)
Weighted mean (95% CI)* Weighted mean (95% CI)* Weighted mean (95% CI)*
Serum creatinine (mg/dl) 0.73 (0.69–0.77) 0.80 (0.76–0.84) 0.79 (0.76–0.81)
Estimated GFR (ml/min/1.73 m2)
CKD-EPI equation†,‡ 114.5 (109.9–119.0) 110.2 (106.9–113.5) 107.7 (105.4–110.1)
MDRD equation†,‡ 116.8 (105.9–127.7) 110.0 (105.8–114.2) 111.1 (107.1–115.0)
Weighted %
(95% CI)*
Unweighted
N¶
Weighted %
(95% CI)*
Unweighted
N¶
Weighted %
(95% CI)*
Unweighted
N¶
KDIGO Kidney disease categoryk
Normal (eGFR ≥90) 87.4 (79.6–92.5) 150 81.6 (76.6–85.7) 266 79.4 (75.5–82.9) 432
Mildly decreased (eGFR
60–89)
10.3 (5.9–17.4) 16 10.9 (8.8–13.5) 37 13.9 (10.3–16.7) 73
Mildly–moderately
decreased (eGFR 45–59)
2.3 (0.8–6.6) 4 4.8 (2.7–8.4) 15 5.3 (3.3–8.2) 30
Moderately–severely
decreased (eGFR 30–44)
0 0 2.4 (0.8–6.9) 7 1.6 (0.9–2.8) 10
Severely decreased
(eGFR 15–29)
0 0 0.3 (0.0–2.3) 1 0.6 (0.1–1.9) 2
Kidney failure
(eGFR <15)
0 0 0 0 0 0
eGFR <60 ml/min/1.73 m2 (CKD-EPI)†,‡
Yes 2.3 (0.8–6.6) 4 7.5 (4.7–11.8) 23 7.4 (5.1–10.6) 42
Age <20 years 0 0 5.6 (1.8–16.3) 2 0 0
Age 20–39 years 0 0 7.6 (4.4–12.6) 15 5.9 (3.1–10.7) 17
Age 40–59 years 8.5 (2.8–22.8) 3 5.5 (1.3–20.6) 3 9.6 (5.1–17.3) 14
Age ≥60 years 7.8 (0.8–46.2) 1 18.6 (5.6–47.1) 3 14.8 (6.9–28.7) 11
eGFR <60 ml/min/1.73 m2 (MDRD)†,‡
Yes 3.7 (1.5–8.5) 6 9.4 (6.0–14.5) 29 10.2 (7.8–13.2) 59
*Values are weighted estimates, adjusted for survey design with sampling weights applied.
†The CKD-EPI eGFR calculations were used as the primary outcomes in this study. The MDRD eGFR calculation is provided for the
sake of comparison.
‡Without coefficient for black race.
¶Actual number of respondents, without sampling weights applied.
kBased on CKD-EPI equation without coefficient for race.
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associated with decreasing mean eGFR. After adjusting
for sex and location, adults aged ≥45 years had a mean
eGFR that was 35 ml/min/1.73 m2 lower than that of
adults under 25 years of age (95% CI = [38, 31]). In
the adjusted analysis, there was also some evidence of a
decrease in mean eGFR with increased ownership of
household items (P = 0.05); however, there was no
evidence of an association with other sociodemographic
factors.
After adjusting for sociodemographic factors, there was
evidence of a decrease in mean eGFR among those with
no daily vigorous activity (3.4 [6.5, 0.3]) compared
with those with who engaged in vigorous activity ≥5 days
a week. There was no evidence of an association with
other behavioural factors. We also observed a decrease in
mean eGFR associated with increasing blood pressure
(adjusted regression coefficients for each 10 mmHg
increase in systolic or diastolic blood pressure: 1.5
[2.5, 0.4] and 1.9 [3.6, 0.1], respectively). There
was also weak evidence of an association with BMI, with
mean eGFR being lowest among obese participants (ad-
justed regression coefficient 4.3 [8.3, 0.3]).
Association of decreased renal function with other
chronic diseases
The adjusted population attributable fraction (PAF) of
decreased renal function due to HIV, hypertension and
diabetes was 6%, 15% and <0.5%, respectively. The
adjusted joint PAF of decreased renal function for all
three risk factors was 21%. Supplementary Table 1 dis-
plays the association between decreased renal function
and three major chronic diseases (hypertension, diabetes
mellitus and HIV) in Mwanza city, district towns and
rural areas. Of note, in district towns, only 7 of 23 adults
with decreased renal function had any of these three
chronic diseases.
Discussion
Decreased renal function (eGFR<60 ml/min/1.73 m2) is
common in north-western Tanzania, particularly after
taking into account the younger age this population. In
our study, the age-standardised prevalence of decreased
renal function was higher in rural areas and district
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Figure 1 Prevalence of decreased renal
function among adults ≥18 years in a
population survey in north-western
Tanzania, age-standardised to the US
population and the WHO world
population.
Table 3 Agreement between different measurements of chronic kidney disease (eGFR <60 ml/min/1.73 m2) using CKD-EPI equation vs
MDRD equation among adults in a population survey in north-western Tanzania, 2012–2013.
eGFR <60 ml/min/1.73 m2
(CKD-EPI)
eGFR <60 ml/min/1.73 m2 (MDRD)
No (N, row %)* Yes (N, row %)* Total (N, %)*
Kappa statistic
(MDRD vs CKD-EPI)
No 949 (97.4%) 25 (2.6%) 969 (100%) 0.83
Yes 0 69 (100%) 69 (100%) P < 0.001
*Actual number of respondents and proportions, without sampling weights applied.
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Table 4 Mean serum creatinine and eGFR, and prevalence of decreased renal function among adults in a population survey in north-
western Tanzania, 2012–2013
Total
N*
Mean
eGFR*
Unadjusted regression
coefficient (95% CI)†
Age, sex and
residence-adjusted regression
coefficient (95% CI)†
Sociodemographic
Residence P = 0.03 P = 0.08
Mwanza city 170 114.9 0 (ref) 0 (ref)
District towns 326 110.4 4.58 [10.67, 1.50] 5.89 [10.94, 0.84]
Rural 547 107.2 7.75 [13.64, 1.87] 4.15 [8.92, 0.62]
Age group P < 0.001 P < 0.001
<25 years 293 124.9 0 (ref) 0 (ref)
25–34 years 326 113.8 11.16 [14.79, 7.53] 11.13 [14.69, 7.58]
35–44 years 167 103.4 21.53 [26.10, 16.96] 21.76 [26.31, 17.21]
≥45 years 257 90.2 34.70 [38.11, 31.29] 34.87 [38.32, 31.42]
Sex P = 0.97 P = 0.18
Male 477 109.4 0 (ref) 0 (ref)
Female 566 109.5 0.05 [2.69, 2.79] 1.56 [3.87, 0.75]
Education P < 0.001 P = 0.48
Secondary or
above
191 116.1 0 (ref) 0 (ref)
Complete
primary
491 109.8 6.25 [10.44, 2.06] 1.33 [2.65, 5.31]
None/incomplete
primary
361 105.5 10.60 [14.58, 6.62] 2.83 [1.83, 7.49]
Marital status P < 0.001 P = 0.31
Married/living as
married
674 107.4 0 (ref) 0 (ref)
Divorced/sep/
widowed
163 99.7 7.62 [12.70, 2.55] 1.53 [5.80, 2.73]
Single 206 124.0 16.65 [12.29, 21.02] 3.11 [1.99, 8.21]
Income per month P = 0.64 P = 0.18
Upper tertile
(64 + USD)
251 108.0 0 (ref) 0 (ref)
Middle tertile
(26–63 USD)
262 109.1 1.12 [3.71, 5.96] 0.50 [3.89, 4.89]
Lower tertile
(<26 USD)
469 109.9 1.90 [2.13, 5.92] 2.69 [0.85, 6.24]
Items owned P = 0.005 P = 0.05
5+ 262 108.3 0 (ref) 0 (ref)
2–4 668 111.0 2.66 [1.80, 7.13] 3.94 [0.60, 7.27]
0–1 113 103.0 5.27 [10.73, 0.20] 0.28 [4.48, 5.04]
Behavioural Adjusted regression
coefficient (95% CI)†,‡
Smoking P < 0.001 P = 0.41 P = 0.43
Never smoked 856 110.8 0 (ref) 0 (ref) 0 (ref)
Ex–smoker 79 101.1 9.70 [15.43, 3.97] 1.20 [5.51, 3.12] 1.16 [5.48, 3.16]
Current smoker 108 105.1 5.69 [11.07, 0.32] 3.35 [1.66, 8.36] 3.16 [1.80, 8.11]
Alcohol
consumption
P = 0.004 P = 0.91 P = 0.82
Never drinks 669 111.4 0 (ref) 0 (ref) 0 (ref)
None in past
12 months
237 106.0 5.40 [9.41, 1.39] 0.16 [3.66, 3.98] 0.20 [3.61, 4.02]
Drinking in past
12 months
137 105.6 5.88 [10.55, 1.20] 0.83 [3.08, 4.74] 1.20 [2.67, 5.07]
Eats fruit/veg less
than 5 days/week
P = 0.08 P = 0.98 P = 0.72
No 771 108.7 0 (ref) 0 (ref) 0 (ref)
Yes 272 111.6 2.88 [0.37, 6.13] 0.03 [2.80, 2.85] 0.49 [3.29, 2.30]
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Table 4 (Continued)
Total
N*
Mean
eGFR*
Unadjusted regression
coefficient (95% CI)†
Age, sex and
residence-adjusted regression
coefficient (95% CI)†
Days of vigorous
physical activity/
week
P = 0.37 P = 0.07 P = 0.09
5+ 500 109.6 0 (ref) 0 (ref) 0 (ref)
1–4 135 112.3 2.66 [2.29, 7.62] 1.82 [6.34, 2.70] 1.59 [6.05, 2.88]
None 407 108.3 1.33 [4.81, 2.15] 3.63 [6.70, 0.55] 3.42 [6.53, 0.31]
Clinical Adjusted regression
coefficient (95% CI)†,§
Body Mass Index
(BMI) category
(kg/m2)
P < 0.001 P = 0.08 P = 0.12
Underweight
(<18.5)
109 108.0 3.80 [10.67, 3.06] 0.78 [4.82, 6.38] 0.89 [4.67, 6.46]
Normal
(18.5–<25)
737 111.8 0 (ref) 0 (ref) 0 (ref)
Overweight
(25–<30)
123 102.8 8.94 [13.98, 3.90] 3.75 [8.69, 1.19] 3.67 [8.68, 1.34]
Obese (≥30) 69 98.8 13.00 [17.34, 8.66] 4.69 [8.70, 0.69] 4.32 [8.34, 0.29]
Central Obesity P = 0.02 P = 0.27 P = 0.34
No 784 111.4 0 (ref) 0 (ref) 0 (ref)
Yes 259 103.7 7.70 [11.77, 3.63] 2.30 [6.46, 1.87] 1.97 [6.07, 2.13]
Hypertension P < 0.001 P = 0.03 P = 0.05
No 863 112.2 0 (ref) 0 (ref) 0 (ref)
Yes 180 96.2 16.00 [20.52, 11.49] 5.45 [10.44, 0.46] 4.85 [9.62, 0.09]
Systolic blood
pressure
<120 mmHg 448 114.4 P < 0.001
3.72 [4.68, 2.76]**
P = 0.006
1.52 [–2.58, 0.46]**
P = 0.007
1.48 [2.52, 0.43]**
120–140 mmHg 445 109.2
>140 mmHg 150 95.4
Diastolic blood
pressure
<80 mmHg 748 112.7 P < 0.001
5.71 [7.42, 4.01]**
P = 0.03
1.93 [3.68, 0.17]**
P = 0.04
1.87 [–3.62, 0.11]**
80–90 mmHg 210 102.7
>90 mmHg 85 97.8
Diabetes¶ P = 0.49 P = 0.41 P = 0.32
No 1031 109.6 0 (ref) 0 (ref) 0 (ref)
Yes 9 102.9 6.66 [26.03, 12.71] 6.65 [9.33, 22.62] 7.68 [7.75, 23.10]
HIV positivek P = 0.30 P = 0.40 P = 0.31
No 947 109.6 0 (ref) 0 (ref) 0 (ref)
Yes 87 106.8 2.73 [8.03, 2.57] 1.78 [2.41, 5.96] 2.09 [2.00, 6.17]
*Actual number of respondents and means, without sampling weights applied.
†Standard errors adjusted for clustering in survey design.
‡Behavioural factors adjusted for age, sex, location and all independent sociodemographic predictors of GFR: number of items owned.
§Clinical factors adjusted for age, sex, location, number of items owned and independent behavioural predictors of GFR: days of vigor-
ous physical activity/week.
¶Missing for three participants.
kHIV diagnosis missing for nine participants.
**Regression coefficient for 10 unit mmHg increase in blood pressure modelled as a linear association with continuous covariate.
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towns than the prevalence of decreased renal function
reported from high-income countries. Prevalences ranged
from 9% in rural areas to 11% in district towns compared
with 6% in the most recent national survey in the United
States [15]. To the best of our knowledge, this is the first
population survey to describe and compare eGFR in adults
in urban, semi-urban and rural areas in SSA. Our results
confirm and extend the results of previous study. In one
recently published community survey of mainly urban
adults in East Africa, the prevalence of kidney disease was
7% [16]. Two population surveys of urban areas of
Central and Southern Africa found a prevalence of
eGFR<60 ml/min/1.73 m2 of 7–8% [17,18], while in rural
West Africa, the prevalence was 5% [10]. These results
are important because an eGFR of 30–60 ml/min/1.73 m2
has been associated with a 20–50% increased risk of all-
cause mortality and a 50–110% increased risk of cardio-
vascular mortality [19]. The health risks related to
decreased renal function may be even higher in African
populations due to limited resources for the diagnosis and
treatment of kidney disease [20,21].
We described the factors associated with decreased
renal function both as a binary and as a continuous vari-
able. Findings in the two models supported one another.
As expected, the factor most strongly associated with low
eGFR was older age. Strikingly, though, decreased renal
function was also common in younger age groups in our
study. Among study subjects, 20- to 39-year-old dwelling
in rural areas and district towns, 6–8% had
eGFR < 60 ml/min/1.73 m2 compared to 0.7% in the US
population [22].
Other factors significantly associated with lower eGFR
included greater relative wealth (as determined by num-
ber of items owned) and high blood pressure. High blood
pressure has consistently been shown to be been associ-
ated with decreased eGFR in prior studies from SSA [16–
18]. Due to the lower prevalence of diabetes mellitus and
obesity (compared to developed countries), hypertension
is relatively more important than these other factors as a
risk factor for kidney disease in our region [5]. Of note,
diabetes mellitus was not associated with decreased renal
function but this may have been due to both the low
prevalence of diabetes mellitus and the fact that, in this
community survey, we may have identified study subjects
who had not had diabetes long enough to develop
nephropathy. Decreased renal function was also associ-
ated with great wealth, as demonstrated in another study
from East Africa [16], but not with higher income.
In our study, only 21% of the decreased renal function
observed was attributable to the combination of hyper-
tension (15%), HIV (6%) and/or diabetes mellitus
(<0.5%). In contrast, a recent study reported that, world-
wide, nearly 60% of kidney disease is jointly attributable
to hypertension (~45%), diabetes mellitus (~25%) and/or
high BMI (~25%) [23]. Given that nearly 80% of
decreased renal function observed in our study was unex-
plained by other chronic diseases, we are planning further
studies to investigate the etiologies of kidney disease in
our population. Schistosomiasis could be an important
cause of kidney disease in our region [24], and we have
already demonstrated a strong association between kid-
ney disease and schistosomiasis in Tanzanian children
[25]. Post-infectious glomerulonephritis is also thought to
be one of the leading causes of kidney disease among
adults in SSA [5], although data are lacking. Traditional
herbal medicine use is also common in SSA, and some
traditional herbs are nephrotoxic [26]. Genetic factors
such as apolipoprotein L1 (APOL1) variants may also
contribute [27]. These infectious, post-infectious and
genetic factors could also explain the comparatively high
prevalence of decreased renal function that we observed
in young adults. Further studies are needed to determine
the relative contribution of these factors to renal disease
in our region as well as other regions of SSA.
District towns had the highest prevalence of decreased
renal function, although the explanation remains uncer-
tain. Of note, mining is the major industry in the two dis-
trict towns included in our study (Kahama and Geita).
Small scale, artisanal gold miners in Tanzania use mer-
cury, which easily enters into the soil and water supply
[28] and can cause decreased renal function [29]. Differ-
ences in incidence of glomerulonephritis or infections
such as malaria could also be contributing. Kidney dis-
ease of unknown cause has also been observed in other
poor, rural and agrarian regions around the globe and
has been variously attributed to pesticide exposure, diet
and hard manual labour [30]. Differences in eGFR
between district towns, cities and rural areas could also
be explained by differences in muscle mass or protein
intake. Further studies are needed to investigate these
possible explanations.
Strengths of our study are its large size and its design
as a population-based representative household survey.
Another strength is the use of the WHO STEPS question-
naire that allows comparison to other studies [8]. In addi-
tion, our study was conducted in close collaboration with
representatives of the Tanzanian Ministry of Health. Our
results are helping to guide the Nephrology Society of
Tanzania (NESOT), a partner of the Ministry of Health
that was established in 2012, in their efforts to expand
screening and treatment services for kidney disease in
Tanzania. The NESOT community screening programme,
which began in urban areas on World Kidney Day 2013,
is now moving towards district towns and rural areas.
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Our study also has limitations. First, because urine was
not collected as part of our community survey, we could
not measure either albuminuria or haematuria. As the
number of participants with low eGFR was relatively
small, particularly in urban areas, the resulting impreci-
sion and wide confidence intervals of our estimates for
urban areas may partly explain the low prevalence of
decreased renal function that we observed. Furthermore,
because there were few outcomes, our estimated ORs and
95% CIs for some risk factors may be biased. Lastly, the
72% response rate observed in our study might have led
to non-response bias, although 90% of households ran-
domly selected for this study and 80% of individuals in
those households did consent to participate. Survivor bias
might also be present and could explain the low preva-
lence of advanced renal disease, as adults with advanced
renal disease usually do not survive long in Tanzania.
In conclusion, our community-based study of a random
sample of urban and rural Tanzanian adults demon-
strated a high prevalence of eGFR < 60 ml/min/1.73 m2
in district towns and rural areas. Low eGFR was more
common in our population than in the US population,
particularly in younger age groups. Only 20% of
decreased renal function could be explained by hyperten-
sion, HIV or diabetes mellitus. Therefore, further
research is needed to identify additional risk factors for
kidney disease in SSA. Importantly, as in Tanzania, kid-
ney disease seems to be even more common than many
other chronic diseases (such as diabetes mellitus), health
services for kidney disease require urgent attention. The
best strategy for whom to screen is yet to be determined,
but these data provide a starting point for planning clini-
cal trials and health service improvements.
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